TY - JOUR
T1 - The demographics and distribution of type B Niemann-Pick disease
T2 - Novel mutations lead to new genotype/phenotype correlations
AU - Simonaro, Calogera M.
AU - Desnick, Robert J.
AU - McGovern, Margaret M.
AU - Wasserstein, Melissa P.
AU - Schuchman, Edward H.
N1 - Funding Information:
The authors acknowledge the many patients and families throughout the world who have contributed valuable time and materials for these studies. In addition, we acknowledge the physicians and scientists who have referred these patients and provided demographic information. In particular, we acknowledge Drs. Aida Al-Aqeel (Saudi Arabia), Guy Besley (United Kingdom), Bruno Bembi (Italy), Eugen Mengel (Germany), Pinar Ozand (Saudi Arabia), Roberto Giugliani (Brazil), Figan Gurakan (Turkey), David Wenger (U.S.A.), W. Ed Wraith (United Kingdom), and Marie Vanier (France). We also thank Ms. Charlene Polin for coordinating the data collection. These studies were supported by a research grant (1 RO1 HD28607) from the National Institutes of Health, a grant (1 P30 HD28822) for the Mount Sinai Child Health Research Center from the National Institutes of Health, and a grant (5 MO1 RR00071) for the Mount Sinai General Clinical Research Center from the National Center for Research Resources at the National Institutes of Health. M.W. is the recipient of a Mentored Patient-Oriented Research Career Development Award (K23 RR16052-01) from the National Institutes of Health.
PY - 2002/12/1
Y1 - 2002/12/1
N2 - We have collected demographic and/or mutation information on a worldwide sample of 394 patients with type B Niemann-Pick disease (NPD). The disorder is panethnic, with the highest incidence occurring in individuals of Turkish, Arabic, and North African descent. Only five of the 394 patients were Ashkenazi Jewish, revealing that, unlike the type A form of NPD, type B NPD does not occur frequently within this population. Mutation analysis of the acid sphingomyelinase (ASM) gene (designated "SMPD1") was performed on 228 patients (324 unique alleles), and several novel, "common" mutations were found. Among these were the L137P, fsP189, and L549P mutations, which accounted for ∼75% of the alleles in Turkish patients, the H421Y and K576N mutations, which accounted for ∼85% of the alleles in Saudi Arabian patients, the S379P, R441X, R474W, and F480L mutations, which accounted for ∼55% of the alleles in Portuguese/Brazilian patients, and the A196P mutation, which accounted for ∼42% of the alleles in Scottish/English patients. The previously reported ΔR608 mutation occurred on ∼12% of the alleles studied. Overall, a total of 45 novel mutations were found, and several new genotype/phenotype correlations were identified. In particular, the L137P, A196P, and R474W mutations were consistent with a less severe form of type B NPD, whereas the H421Y and K576N mutations led to an early-onset, more severe form that was specific to Saudi Arabia. These data provide the first extensive demographic assessment of this disorder and describe several new mutations that can be used to predict phenotypic outcome and to gain new insights into the structure and function of ASM.
AB - We have collected demographic and/or mutation information on a worldwide sample of 394 patients with type B Niemann-Pick disease (NPD). The disorder is panethnic, with the highest incidence occurring in individuals of Turkish, Arabic, and North African descent. Only five of the 394 patients were Ashkenazi Jewish, revealing that, unlike the type A form of NPD, type B NPD does not occur frequently within this population. Mutation analysis of the acid sphingomyelinase (ASM) gene (designated "SMPD1") was performed on 228 patients (324 unique alleles), and several novel, "common" mutations were found. Among these were the L137P, fsP189, and L549P mutations, which accounted for ∼75% of the alleles in Turkish patients, the H421Y and K576N mutations, which accounted for ∼85% of the alleles in Saudi Arabian patients, the S379P, R441X, R474W, and F480L mutations, which accounted for ∼55% of the alleles in Portuguese/Brazilian patients, and the A196P mutation, which accounted for ∼42% of the alleles in Scottish/English patients. The previously reported ΔR608 mutation occurred on ∼12% of the alleles studied. Overall, a total of 45 novel mutations were found, and several new genotype/phenotype correlations were identified. In particular, the L137P, A196P, and R474W mutations were consistent with a less severe form of type B NPD, whereas the H421Y and K576N mutations led to an early-onset, more severe form that was specific to Saudi Arabia. These data provide the first extensive demographic assessment of this disorder and describe several new mutations that can be used to predict phenotypic outcome and to gain new insights into the structure and function of ASM.
UR - http://www.scopus.com/inward/record.url?scp=0036914191&partnerID=8YFLogxK
U2 - 10.1086/345074
DO - 10.1086/345074
M3 - Article
C2 - 12369017
AN - SCOPUS:0036914191
SN - 0002-9297
VL - 71
SP - 1413
EP - 1419
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -